Company: MYSEW
Filing Date: 2025-11-26
Form Type: S-3
Source: 0001213900-25-115502
Chunk: 2

Company: Myseum, Inc.
Filing Date: 2025-11-26
Form: S-3
Chunk 2
---
, 2022
(the “Prior Registration Statement”). Filing fees of $1,994.63 were previously paid with respect to the Unsold Securities.
Pursuant to Rule 415(a)(5) under the Securities Act, the Registrant intends to continue to offer and sell the Unsold Securities
under the Prior Registration Statement until the earlier of (i) the date on which this registration statement is declared effective by
the Securities and Exchange Commission, and (ii) June 4, 2026, which is 180 days after the third-year anniversary of the effective date
of the Prior Registration Statement (the “Expiration Date”). Until the Expiration Date, the Registrant may continue to use
the Prior Registration Statement and related prospectus supplements for its offerings thereunder.

The information in this prospectus is not complete and may be changed. We may not sell these securities or accept an offer to buy these securities until the registration statement filed with the U.S. Securities and Exchange Commission is effective. This prospectus is not an offer to sell these securities, and we are not soliciting an offer to buy these securities in any state where the offer or sale is not permitted.

<div align='center'>PRELIMINARY PROSPECTUS

Subject to completion, dated November 26, 2025

Myseum, Inc.

Common Stock
Preferred Stock
Debt Securities
Warrants
Rights
Units</div>

We may offer and sell,
from time to time in one or more offerings, any combination of common stock, preferred stock, debt securities, warrants to purchase common
stock, preferred stock or debt securities, or any combination of the foregoing, either individually or as units comprised of one or more
of the other securities, having an aggregate initial offering price not exceeding $25,000,000

This prospectus provides
a general description of the securities we may offer. Each time we sell a particular class or series of securities, we will provide specific
terms of the securities offered in a supplement to this prospectus. The prospectus supplement and any related free writing prospectus
may also add, update or change information contained in this prospectus. We may also authorize one or more free writing prospectuses
to be provided to you in connection with these offerings. You should read carefully this prospectus, the applicable prospectus supplement
and any related free writing prospectus, as well as any documents incorporated by reference herein or therein before you invest in any
of our securities.

The specific terms